Regencell Bioscience Holdings Limited, a herbal medicine biotech firm, has experienced an astonishing 46,000% surge in its stock value in 2025, despite generating no revenue since its inception. This Hong Kong-based company, specializing in traditional Chinese medicine for neurological conditions, saw its market capitalization soar to $30 billion.
Related Posts
Promptly counter fake news, top officials told
The Indian government is taking steps to combat the spread of fake news and misinformation on social media. The Cabinet Secretariat has directed all secretaries […]
German court says FB users affected by hacking eligible for compensation, Meta responds
Germany’s highest court ruled that Meta might have to compensate users whose data was potentially compromised in 2018 and 2019. The court stated that users […]
EC counters Congress charges over Maharashtra polling data
The Election Commission clarified the rise in voter turnout in Maharashtra on polling day is part of a normal process, addressing Congress’s concerns. Between 5 […]